Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)

Market Cap	6.87B +41.7%
Revenue (ttm)	2.87B -18.3%
Net Income	16.30M -89.3%
EPS	0.01 -89.2%
Shares Out	1.09B
PE Ratio	421.47
Forward PE	n/a
Dividend	0.10 (1.43%)
Ex-Dividend Date	Jun 12, 2025

Volume	102,201,168
Average Volume	107,502,979
Open	6.11
Previous Close	6.29
Day's Range	5.93 - 6.22
52-Week Range	3.68 - 8.44
Beta	-0.03
RSI	58.08
Earnings Date	Apr 25, 2026

About SHA:600488

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company’s primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as preparations, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation prepar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 2,884
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600488

Financial Performance

In 2024, SHA:600488's revenue was 3.22 billion, a decrease of -15.00% compared to the previous year's 3.78 billion. Earnings were 133.45 million, an increase of 14.01%.